✦ LIBER ✦

Docetaxel in the treatment of prostate cancer: Opportunities for combination regimens and challenges to development

✍ Scribed by Christopher J Logothetis

Book ID: 114105350
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 194 KB
Volume: 28
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(01)90147-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Challenges and opportunities to the desi

Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer

✍ Ian M Thompson; Joseph A Basler; Robin Leach; Dean Troyer; Eric Klein; Otis Braw 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Differential effects of ibandronate, doc

Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines

✍ Epplen, Robin; Stöckle, Michael; Engelmann, Udo; Heidenreich, Axel; Ohlmann, Car 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 148 KB

Phase II study of gemcitabine and doceta

Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer

✍ Shom GOEL; Ehtesham ABDI; Craig R LEWIS; Matthew LINKS; Steven BEGBIE; Philip CL 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

308 IMPACT OF PSA FLARE-UP UNDER THE COM

308 IMPACT OF PSA FLARE-UP UNDER THE COMBINED TREATMENT WITH DOCETAXEL AND ESTRAMUSTINE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER

✍ T. Nelius; T. Klatte; W. De Riese; S. Filleur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 316 KB

710 DOSE FINDING AND EFFICACY PHASE 2 ST

710 DOSE FINDING AND EFFICACY PHASE 2 STUDY OF INECALCITOL, A NEW VDR AGONIST, IN COMBINATION WITH DOCETAXEL-PREDNISONE REGIMEN FOR CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS (PTS)

✍ Medioni, Jacques; Deplanque, Gael; Maurina, Tristan; Ferrero, Jean-Marc; Rodier, 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 150 KB

Aflibercept versus placebo in combinatio

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB